Cargando…
Reshaping Treatment of Heart Failure with Preserved Ejection Fraction
Current data indicate that in the community, approximately 50% of patients with heart failure (HF) have preserved left ventricular (LV) ejection fraction (LVEF)—the so-called HFpEF. Treatment of HFpEF has been considered an unmet need for decades. We believe that the main underlying reasons have bee...
Autores principales: | Karamichalakis, Nikolaos, Xanthopoulos, Andrew, Triposkiadis, Filippos, Paraskevaidis, Ioannis, Tsougos, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267897/ https://www.ncbi.nlm.nih.gov/pubmed/35806994 http://dx.doi.org/10.3390/jcm11133706 |
Ejemplares similares
-
Medical Treatment in Heart Failure with Reduced Ejection Fraction: A Proposed Algorithm Based on the Patient’s Electrolytes and Congestion Status
por: Paraskevaidis, Ioannis, et al.
Publicado: (2023) -
Human Gut Microbiota in Heart Failure: Trying to Unmask an Emerging Organ
por: Paraskevaidis, Ioannis, et al.
Publicado: (2023) -
Heart failure with preserved ejection fraction: A distinct heart failure phenotype?
por: Triposkiadis, Filippos, et al.
Publicado: (2022) -
Heart failure with reduced, mildly reduced, or preserved left ventricular ejection fraction: Has reasoning been lost?
por: Xanthopoulos, Andrew, et al.
Publicado: (2022) -
The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF
por: Triposkiadis, Filippos, et al.
Publicado: (2023)